2024-11-22 Emeren Group Ltd HaiPress

NORWALK,Conn.,Nov. 21,2024 -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL),a leading global solar project developer,owner,and operator,today announced its participation in the following investor conferences:
Janney's 2nd Annual Clean Energy Investment Symposium on December 4-5,2024,in New Orleans,LA.
BofA Securities 2024 Clean Energy Symposium on December 5-6,in New York,NY. The management team will present at a panel at 3:30 p.m. Eastern Time on December 5.
Management will be available for one-on-one and small group meetings with institutional investors at each of these events. Portfolio managers and analysts who wish to request a meeting should contact their institutional sales representative at each sponsoring bank.
About Emeren Group Ltd
Emeren Group Ltd (NYSE: SOL),a renewable energy leader,showcases a comprehensive portfolio of solar projects and Independent Power Producer (IPP) assets,complemented by a significant global Battery Energy Storage System (BESS) capacity. Specializing in the entire solar project lifecycle — from development through construction to financing — we excel by leveraging local talent in each market,ensuring our sustainable energy solutions are at the forefront of efficiency and impact. Our commitment to enhancing solar power and energy storage underlines our dedication to innovation,excellence,and environmental responsibility. For more information,go to www.emeren.com.
For investor and media inquiries,please contact:
Emeren Group Ltd- Investor Relations
+1 (925) 425-7335
ir@emeren.com
The Blueshirt Group
GaryDvorchak
+1 (323) 240-5796
gary@blueshirtgroup.co
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Diet Tips Daily